Wenyan Sun

Dr. Wenyan Sun

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2024 in Stroke
Verified
Journal Article
Open access
WSWenyan Sun
Wenyan Sun
VTVirendra Tiwari
Virendra Tiwari
GDGrace Davis
Grace Davis
GZGuokun Zhou
Guokun Zhou
SJSarun Jonchhe
Sarun Jonchhe
XZXiangming Zha
Xiangming Zha
BACKGROUND: In ischemia, acidosis occurs in/around injured tissue and parallels disease progression. Therefore, targeting an acid-sensitive receptor offers unique advantages in achieving the spatial and temporal specificity required for therapeutic interventions. We previously demonstrated that increased expression of GPR68 (G protein-coupled receptor 68), a proton-sensitive G protein-coupled receptor, mitigates ischemic brain injury. Here, we investigated the mechanism underlying GPR68-dependent protection. METHODS: We performed biochemical and molecular analyses to examine poststroke signaling. We used in vitro brain slice cultures and in vivo mouse transient middle cerebral artery occlusion (tMCAO) models to investigate ischemia-induced injuries. RESULTS: GPR68 deletion reduced PERK (protein kinase R-like ER kinase) expression in mouse brain. Compared with the wild-type mice, the GPR68-/- (knockout) mice exhibited a faster decline in eIF2α (eukaryotic initiation factor-2α) phosphorylation after tMCAO. Ogerin, a positive modulator of GPR68, stimulated eIF2α phosphorylation at 3 to 6 hours after tMCAO, primarily in the ipsilateral brain tissue. Consistent with the changes in eIF2α phosphorylation, Ogerin enhanced tMCAO-induced reduction in protein synthesis in ipsilateral brain tissue. In organotypic cortical slices, Ogerin reduced pH 6 and oxygen-glucose deprivation–induced neurotoxicity. Following tMCAO, intravenous delivery of Ogerin reduced brain infarction in wild-type but not knockout mice. Coapplication of a PERK inhibitor abolished Ogerin-induced protection. Delayed Ogerin delivery at 5 hours after tMCAO remained protective, and Ogerin has a similar protective effect in females. Correlated with these findings, tMCAO induced GPR68 expression at 6 hours, and Ogerin alters post-tMCAO proinflammatory/anti-inflammatory cytokine/chemokine expression profile. CONCLUSIONS: These data demonstrate that GPR68 potentiation leads to neuroprotection, at least in part, through enhancing PERK-eIF2α activation in ischemic tissue but has little impact on healthy tissue.

5 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
PRPaulino Ramirez
Paulino Ramirez
WSWenyan Sun
Wenyan Sun
SDShiva Kazempour Dehkordi
Shiva Kazempour Dehkordi
HZHabil Zare
Habil Zare
BFBernard Fongang
Bernard Fongang
BFBess Frost
Bess Frost
Studies in laboratory models and postmortem human brain tissue from patients with Alzheimer’s disease have revealed disruption of basic cellular processes such as DNA repair and epigenetic control as drivers of neurodegeneration. While genomic alterations in regions of the genome that are rich in repetitive sequences, often termed “dark regions,” are difficult to resolve using traditional sequencing approaches, long-read technologies offer promising new avenues to explore previously inaccessible regions of the genome. In the current study, we leverage nanopore-based long-read whole-genome sequencing of DNA extracted from postmortem human frontal cortex at early and late stages of Alzheimer’s disease, as well as age-matched controls, to analyze retrotransposon insertion events, non-allelic homologous recombination (NAHR), structural variants and DNA methylation within retrotransposon loci and other repetitive/dark regions of the human genome. Interestingly, we find that retrotransposon insertion events and repetitive element-associated NAHR are particularly enriched within centromeric and pericentromeric regions of DNA in the aged human brain, and that ribosomal DNA (rDNA) is subject to a high degree of NAHR compared to other regions of the genome. We detect a trending increase in potential somatic retrotransposition events of the small interfering nuclear element (SINE) AluY in late-stage Alzheimer’s disease, and differential changes in methylation within repetitive elements and retrotransposons according to disease stage. Taken together, our analysis provides the first long-read DNA sequencing-based analysis of retrotransposon sequences, NAHR, structural variants, and DNA methylation in the aged brain, and points toward transposable elements, centromeric/pericentromeric regions and rDNA as hotspots for genomic variation.

11 November 2026 in Cells
Verified
Journal Article
Open access
PDF file
YZYoufang Zhou
Youfang Zhou
ABAngela Barattini
Angela Barattini
XZXiangming Zha
Xiangming Zha
WSWenyan Sun
Wenyan Sun
Retrotransposons are repetitive DNA elements that are normally suppressed through epigenetic mechanisms. In aging and neurodegenerative diseases, abnormal retrotransposon activation occurs and can worsen neurotoxicity. However, it remains unclear whether ischemic stroke induces changes in retrotransposon transcript levels between infarct and peri-infarct brain tissue and whether the abundance of retrotransposon transcripts differs between these regions. To answer this question, we performed 45 min of transient middle cerebral artery occlusion (tMCAO) followed by reperfusion on adult wild-type male mice, then measured expression of retrotransposons LINE-1, IAP and SINE B2 in infarct and peri-infarct brain tissues using RT-qPCR. Next, we performed Western blotting to determine retroviral GAG protein expression. Since brain ischemia leads to tissue acidosis, which exhibits a positive correlation with ischemic brain injury, we further asked whether acidosis itself alters retrotransposon expression. We exposed neuro-2a (N2A) cells to acidic extracellular pH (6.4 or 6.0) and analyzed retrotransposon transcript levels. tMCAO significantly increased transcript abundance of LINE-1 Orf1, IAPEz-gag, IAPEY4 and B2 in ipsilateral ischemic brain tissue compared with sham controls at 24 h. Following correction of the four paired regional comparisons, only the difference in IAPEz-gag expression between infarct and corresponding contralateral region remained statistically significant. Western blotting analysis revealed changes in the abundance and patterns of GAG-immunoreactive proteins, including decreased precursor Pr65 abundance at 6 h of reperfusion, and reduced levels of both Pr65 and mature capsid p30 products at 24 h. In N2A cells, extracellular acidosis was associated with time-dependent increases in the abundance of LINE-1 Orf1, IAPEz-gag and B2 transcripts. Increased cellular injury was also observed under these conditions and may have contributed to these changes. These data suggest distinct retrotransposon transcript profiles between infarct and peri-infarct regions following focal ischemia–reperfusion. Although the in vitro results do not establish whether the transcript changes are attributable to extracellular acidosis, associated cellular injury, or both, exposure to acidic conditions was associated with a subset of the retrotransposon transcript changes observed in ischemic brain tissue. These findings provide a foundation for further investigation of retrotransposon dysregulation in stroke pathology.

6 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YZYoufang Zhou
Youfang Zhou
ABAngela Barattini
Angela Barattini
XZXiangming Zha
Xiangming Zha
WSWenyan Sun
Wenyan Sun
Retrotransposons are repetitive DNA elements normally suppressed through epigenetic mechanisms. In aging and neurodegenerative diseases, abnormal retrotransposon activation occurs and leads to neurotoxicity. However, whether ischemic stroke induces retrotransposon activation remains unclear. Here, we investigated whether cerebral ischemia triggers dysregulation of retrotransposon in the brain. Since brain ischemia leads to tissue acidosis, we further examined whether acidosis contributes to this response. We performed 45 min of transient middle cerebral artery occlusion (tMCAO) followed by reperfusion on adult wild-type mice, then measured expression of retrotransposons LINE-1, IAP, ETn2 and SINE B2 in ipsilateral brain tissue using RT-qPCR. Retroviral GAG protein expression was examined by Western blotting. In vitro, we exposed neuro-2a (N2A) cells to acidic extracellular pH (6.4 or 6.0) and retrotransposon transcripts were analyzed. We found that ischemia-reperfusion increased expression of IAPEz-gag and ETn2 in ipsilateral ischemic brain tissue at 24 h, with stronger induction of LINE-1 Orf1, IAPEz-gag and B2 in infarct than peri-infarct brain regions. Western blotting analysis revealed dynamic changes in GAG proteins, with no detectable changes at 6 h of reperfusion followed by reduced levels of the precursor Pr65 and mature capsid p30 products at 24 h. In N2A cells, extracellular acidosis induced time-dependent increases in LINE-1 Orf1, IAPEz-gag and B2 transcripts. These findings identify retrotransposon dysregulation as a molecular feature of ischemic brain injury and provide a framework for further investigating its role in stroke pathology.